Inhaled nitric oxide for COPD: a clinical study
Part of Lungs & breathing clinical trials.
This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 75 years old.
- You must have a history of smoking at least 10 pack-years (for example, smoking 1 pack a day for 10 years) and have quit for at least 1 month before the study.
- You must have moderate to severe COPD confirmed by a breathing test showing FEV1/FVC less than 0.7 and FEV1 between 30% and 80% of normal.
- You must not have used any nicotine products (like patches or gum) in the past month.
- You must not have had a COPD flare-up in the last month that required steroids by mouth or IV, and you must not have certain heart problems or other serious illnesses.
- You must be able to give written consent and follow study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a measurement of inflammation in the breath (called fractional exhaled nitric oxide) relates to COPD flare-ups in people who are already using a triple inhaler therapy. It aims to find better ways to predict and manage COPD exacerbations.
This study looks at how a breathing treatment called nasal high-flow therapy affects lung function over time in people with severe chronic obstructive pulmonary disease (COPD). It may help patients understand if this therapy could be useful for managing their condition.
This trial tests a device that briefly opens your airways to help release trapped air after exercise. It may reduce shortness of breath and improve your daily life with COPD.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This early trial tests whether inhaled nitric oxide changes how well your lungs exchange gases during exercise in people with COPD, and compares results with healthy volunteers. It may help researchers understand lung blood-flow and breathing differences that could affect symptoms and exercise tolerance.
This trial tests whether giving nitric oxide gas through a breathing tube can improve oxygen levels in patients with severe obesity who are on a ventilator. It may help those whose lungs are struggling due to acute respiratory failure.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.